Phase 2 Study: An Open-Label, Randomized, Phase 2 Dose-Finding Study of Pacritinib in Patients With Primary Myelofibrosis, Post-Polycythemia Vera Myelofibrosis, or Post- Essential Thrombocythemia Myelofibrosis Previously Treated With Ruxolitinib

SE AOK I. sx. Belgyogyaszati Klinika, Budapest

Debreceni Egyetem Klinikai Központ, Debrecen

Somogy Megyei Kaposi Mór Oktató Kórház, Kaposvár

Weill Cornell Medical College, New York

Icahn School of Medicine at Mount Sinai, New York

Columbia University, New York

Memorial Sloan-Kettering Cancer Center, New York

University of Rochester, Rochester

Medical Faculty Associates, Inc., Washington D.C.

ASST Monza - Ospedale San Gerardo, Monza

Saint Agnes Hospital, Baltimore

Skane University Hospital Lund, Lund

Duke University Hospital, Durham

Hospital Universitario Ramón y Cajal, Madrid

CHU de Nimes - Hopital Universitaire Caremeau, Nîmes

Clínica Universidad de Navarra, Pamplona

Centre Hospitalier Universitaire de Toulouse- Hôpital Purpan, Toulouse

Florida Cancer Specialists & Research Institute, West Palm Beach

CHU Hopitaux de Bordeaux - Hôpital Haut-Lévêque, Pessac

Florida Cancer Specialists & Research Institute, St. Petersburg

Florida Cancer Specialists & Research Institute, Fort Myers

Tennessee Oncology, Nashville

Vanderbilt-Ingram Cancer Center, Nashville

Yeungnam University Medical Center, Daegu

The Ohio State University Comprehensive Cancer Center, Columbus

Cleveland Clinic, Cleveland

Istituto Scientifico Romagnolo per lo Studio e la Cura Dei Tumori, Meldola

University of Michigan Comprehensive Cancer Center, Ann Arbor

Azienda Ospedaliero-Universitaria Careggi, Florence

Centre Hospitalier Regional Universitaire de Lille - Hopital Claude Huriez, Lille

Northwestern University Feinberg School of Medicine, Chicago

The University of Chicago Medical Center, Chicago

Washington University School of Medicine in St. Louis, St Louis

University of Kansas Cancer Center, Westwood

Centre Hospitalier Lyon-Sud, Pierre-Bénite

Ochsner Medical Center, New Orleans

Orebro University Hospital, Örebro

Hôpital Saint-Louis, Paris

The University of Texas MD Anderson Cancer Center, Houston

University of Texas Health Science Center at San Antonio School of Medicine, San Antonio

CHU Hopital Sud, Amiens

University of Utah School of Medicine, Salt Lake City

Mayo Clinic Hospital, Phoenix

USC Norris Comprehensive Cancer Center, Los Angeles

UCLA Jonsson Comprehensive Cancer Center, Los Angeles

City of Hope, Duarte

Stanford Cancer Institute, Stanford

Fred Hutchinson Cancer Research Center, Seattle

Yale School of Medicine, New Haven

Dana-Farber Cancer Institute, Boston

Hackensack University Medical Center, Hackensack

Severance Hospital, Seoul

Samsung Medical Center, Seoul

The Catholic University of Korea, Seoul St. Mary's Hospital, Seoul

Hospital del Mar, Barcelona

Hospital Clínic de Barcelona, Barcelona

Beatson West of Scotland Cancer Center, Glasgow

Barts Health NHS Trust - The Royal London Hospital, London

Guy's and St Thomas' NHS Foundation Trust - Guy's Hospital, London

Imperial College Healthcare NHS Trust - Hammersmith Hospital, London

The Christie NHS Foundation Trust, Manchester

Oxford University Hospitals NHS Trust - Churchill Hospital, Oxford